Determination of 32 cathinone derivatives and other designer drugs in serum by comprehensive LC-QQQ-MS/MS analysis

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Analytical and Bioanalytical Chemistry

• Publication date

  2013-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00216-012-6548-8PMID 23180084
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Toxicology of Bath Salts: A Review of Synthetic Cathinones

  2012cited by this paper
• Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food".

  2012cited by this paper
• Designer drugs: a medicinal chemistry perspective

  2012cited by this paper
• Detection and quantification of new designer drugs in human blood: Part 2 - Designer cathinones.

  2012cited by this paper
• Aspects of matrix effects in applications of liquid chromatography–mass spectrometry to forensic and clinical toxicology—a review

  2012cited by this paper
• Determination of cathinones and related ephedrines in forensic whole-blood samples by liquid-chromatography-electrospray tandem mass spectrometry.

  2011cited by this paper
• Clinical toxicology of newer recreational drugs

  2011cited by this paper
• Development of a rapid LC-MS/MS method for direct urinalysis of designer drugs.

  2011cited by this paper
• Simultaneous detection of ten psychedelic phenethylamines in urine by gas chromatography-mass spectrometry.

  2011cited by this paper
• BZP-party pills: a review of research on benzylpiperazine as a recreational drug.

  2011cited by this paper
• Bioanalysis of new designer drugs.

  2010cited by this paper
• LC-MS/MS screening method for designer amphetamines, tryptamines, and piperazines in serum

  2010cited by this paper
• Key aspects of analytical method validation and linearity evaluation.

  2009cited by this paper
• Investigation of the first deaths in the United Kingdom involving the detection and quantitation of the piperazines BZP and 3-TFMPP.

  2008cited by this paper
• Validation of new methods.

  2007cited by this paper
• Determination of illicit drugs and their metabolites in human urine by liquid chromatography tandem mass spectrometry including relative ion intensity criterion.

  2007cited by this paper
• A demonstration of the use of ultra-performance liquid chromatography-mass spectrometry [UPLC/MS] in the determination of amphetamine-type substances and ketamine for forensic and toxicological analysis.

  2006cited by this paper
• A fatal poisoning with 5-methoxy-N,N-diisopropyltryptamine, Foxy.

  2006cited by this paper
• Fatality Due to Acute α-Methyltryptamine Intoxication

  2005cited by this paper
• Fatality due to acute alpha-methyltryptamine intoxication.

  2005cited by this paper
• A general screening and confirmation approach to the analysis of designer tryptamines and phenethylamines in blood and urine using GC-EI-MS and HPLC-electrospray-MS.

  2004cited by this paper
• Structure elucidation of nanogram quantities of unknown designer drugs based on phenylalkylamine derivates by ion trap multiple mass spectrometry

  2004cited by this paper
• Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS.

  2003cited by this paper
• Rational experimental design for bioanalytical methods validation. Illustration using an assay method for total captopril in plasma.

  1996cited by this paper
• Designer drugs: past history and future prospects.

  1988cited by this paper

• Two is better than one: deuterium in analytical mass spectrometry

  2024cites this paper
• Impurities in over-the-counter pseudoephedrine leading to methcathinone detection in urine.

  2024cites this paper
• Comparison of the applicability of electromembrane extraction and liquid-phase microextraction for extraction of non-polar basic drugs from different biological samples: Using clozapine as the model analyte.

  2024cites this paper
• Detection of synthetic cathinones in seized drugs using surface-enhanced Raman spectroscopy (SERS)

  2024cites this paper
• Efficient flat membrane based liquid phase microextraction of cathinones from environmental water and biological samples

  2023cites this paper
• Development of a dispersive liquid-liquid microextraction for synthetic cathinones in biological fluids based on principles of Green Analytical Toxicology.

  2023cites this paper
• Recent advances in analysis of new psychoactive substances by means of liquid chromatography coupled with low-resolution tandem mass spectrometry

  2023influential citation
• Comparison of LC-MS and LC-DAD Methods of Detecting Abused Piperazine Designer Drugs

  2022cites this paper
• Overview of analytical methods for determining novel psychoactive substances, drugs and their metabolites in biological samples

  2022cites this paper
• Ultrasound-assisted electromembrane extraction with supported semi-liquid membrane.

  2021cites this paper
• An updated review on synthetic cathinones

  2021cites this paper
• Rapid Targeted Method of Detecting Abused Piperazine Designer Drugs

  2021cites this paper
• Sensitive determination of illicit drugs in wastewater using enrichment bag-based liquid-phase microextraction and liquid-chromatography tandem mass spectrometry.

  2021cites this paper
• Development, validation and evaluation of a quantitative method for the analysis of twenty-four new psychoactive substances in oral fluid by LC–MS/MS

  2020cites this paper
• Piperazine derivatives as dangerous abused compounds

  2020cites this paper
• New and Emerging Illicit Psychoactive Substances

  2020cites this paper
• Synthetic cathinones - From natural plant stimulant to new drug of abuse.

  2020cites this paper
• Development of Improved Extraction/Purification Methods and Comprehensive Screening/Confirmation by LC-QqQ-MS Analysis for Novel Psychoactive Substances

  2020influential citation
• Solid-phase extraction-liquid chromatography-tandem mass spectrometry method for the qualitative analysis of 61 synthetic cannabinoid metabolites in urine.

  2019cites this paper
• A LC-MS/MS method for the determination of common synthetic cathinones in meconium.

  2019cites this paper
• Development and validation of a GC–MS/MS method for the determination of 11 amphetamines and 34 synthetic cathinones in whole blood

  2019cites this paper
• Ion mobility spectrometry as a fast screening tool for synthetic cannabinoids to uncover drug trafficking in jail via herbal mixtures, paper, food, and cosmetics.

  2019cites this paper
• Review of Bath Salts on Illicit Drug Market

  2019cites this paper
• Systematic analysis of novel psychoactive substances. II. Development of a screening/confirmatory LC-QqQ-MS/MS method for 800+ compounds and metabolites in urine

  2019cites this paper
• Detection and Quantitation of Hazardous Chemicals in Environmental Matrices using Paper Spray Mass Spectrometry

  2019cites this paper
• Development of a quantitative approach in blood plasma for low-dosed hallucinogens and opioids using LC-high resolution mass spectrometry.

  2018cites this paper
• MDPV in forensic routine cases: Psychotic and aggressive behavior in relation to plasma concentrations.

  2018cites this paper
• Analytical Methods Used for Identification and Determination of Synthetic Cathinones and Their Metabolites

  2018cites this paper
• Systematic analysis of novel psychoactive substances. I. Development of a compound database and HRMS spectral library

  2018cites this paper
• Fatal Poisonings Associated with New Psychoactive Substances.

  2018cites this paper
• New and Emerging Illicit Psychoactive Substances.

  2018cites this paper
• Forensic Toxicological Screening and Confirmation of 800+ Novel Psychoactive Substances by LC-QTOF-MS and 2D-LC Analysis

  2018cites this paper
• The Analytical Challenge in the Determination of Cathinones, Key-Players in the Worldwide Phenomenon of Novel Psychoactive Substances

  2018cites this paper
• Separation of enantiomers of new psychoactive substances by high-performance liquid chromatography.

  2018cites this paper
• A fast bioanalytical method based on microextraction by packed sorbent and UPLC-MS/MS for determining new psychoactive substances in oral fluid.

  2017cites this paper
• A case of fatal idiosyncratic reaction to the designer drug 3,4-methylenedioxypyrovalerone (MDPV) and review of the literature

  2017cites this paper
• Identification of five pyrrolidinyl substituted cathinones and the collision-induced dissociation of electrospray-generated pyrrolidinyl substituted cathinones.

  2017cites this paper
• Determination of 74 new psychoactive substances in serum using automated in-line solid-phase extraction-liquid chromatography-tandem mass spectrometry.

  2017cites this paper
• Identification and analytical characterization of four synthetic cathinone derivatives iso-4-BMC, β-TH-naphyrone, mexedrone, and 4-MDMC.

  2017cites this paper
• Clinical Interpretation of Urine Drug Tests: What Clinicians Need to Know About Urine Drug Screens

  2017cites this paper
• Solid-phase extraction followed by liquid chromatography-high resolution mass spectrometry to determine synthetic cathinones in different types of environmental water samples.

  2017cites this paper
• Comparison of ultra high performance supercritical fluid chromatography, ultra high performance liquid chromatography, and gas chromatography for the separation of synthetic cathinones.

  2017cites this paper
• The role of diode array ultraviolet detection for the identification of synthetic cathinones.

  2017cites this paper
• Identification and classification of new psychoactive substances using Raman spectroscopy and chemometrics

  2017cites this paper
• Development of an enantioseparation method for novel psychoactive drugs by HPLC using a Lux® Cellulose-2 column in polar organic phase mode.

  2017cites this paper
• Separation of enantiomers of New Psychoactive Substances by HPLC

  2017cites this paper
• LC-MS/MS and volumetric absorptive microsampling for quantitative bioanalysis of cathinone analogues in dried urine, plasma and oral fluid samples.

  2016cites this paper
• Review and Recommendations for Drug Testing in Substance Use Treatment Contexts

  2016cites this paper
• Simple and rapid screening procedure for 143 new psychoactive substances by liquid chromatography-tandem mass spectrometry.

  2016cites this paper
• Modified HPLC–ESI–MS Method for Glycated Hemoglobin Quantification Based on the IFCC Reference Measurement Procedure and Its Application for Quantitative Analyses in Clinical Laboratories of China

  2016cites this paper
• Regal electrochemistry: sensing of the synthetic cathinone class of new psychoactive substances (NPSs)

  2015cites this paper
• An overview of recent developments in the analytical detection of new psychoactive substances (NPSs).

  2015cites this paper
• Detection and quantification of 56 new psychoactive substances in whole blood and urine by LC-MS/MS.

  2015cites this paper
• Fast separation of selected cathinones and phenylethylamines by supercritical fluid chromatography.

  2015cites this paper
• Comprehensive review of the detection methods for synthetic cannabinoids and cathinones

  2015cites this paper
• Detection of Gelatin Adulteration in Traditional Chinese Medicine: Analysis of Deer-Horn Glue by Rapid-Resolution Liquid Chromatography-Triple Quadrupole Mass Spectrometry

  2015cites this paper
• Analysis of new designer drugs in post-mortem blood using high-resolution mass spectrometry.

  2015cites this paper
• Rapid screening of 35 new psychoactive substances by ion mobility spectrometry (IMS) and direct analysis in real time (DART) coupled to quadrupole time-of-flight mass spectrometry (QTOF-MS).

  2015cites this paper
• Chiral separation of 12 cathinone analogs by cyclodextrin‐assisted capillary electrophoresis with UV and mass spectrometry detection

  2014cites this paper
• Liquid chromatography tandem mass spectrometry determination of selected synthetic cathinones and two piperazines in oral fluid. Cross reactivity study with an on-site immunoassay device.

  2014cites this paper
• Drugs Involved in Drug-Facilitated Crimes (DFC): Analytical Aspects: 1—Blood and Urine

  2014cites this paper
• Quality Assurance of forensic investigations in toxicology and traffic safety

  2014cites this paper
• Utilization of micellar electrokinetic chromatography-tandem mass spectrometry employed volatile micellar phase in the analysis of cathinone designer drugs.

  2014cites this paper
• Analysis of synthetic cathinones and associated psychoactive substances by ion mobility spectrometry.

  2014cites this paper
• Emerging drugs of abuse.

  2014cites this paper
• Using cheminformatics to predict cross reactivity of “designer drugs” to their currently available immunoassays

  2014cites this paper
• Forensic electrochemistry: the electroanalytical sensing of synthetic cathinone-derivatives and their accompanying adulterants in "legal high" products.

  2014cites this paper
• Screening for new psychoactive substances in hair by ultrahigh performance liquid chromatography-electrospray ionization tandem mass spectrometry.

  2014cites this paper
• Drugs and other chemicals involved in fatal poisoning in England and Wales during 2000–2011

  2014cites this paper
• Identification and quantitation of a new cathinone designer drug PV9 in an “aroma liquid” product, antemortem whole blood and urine specimens, and a postmortem whole blood specimen in a fatal poisoning case

  2014cites this paper
• Rapid and simple LC-MS/MS screening of 64 novel psychoactive substances using dried blood spots.

  2014cites this paper
• Postmortem distribution of α-pyrrolidinovalerophenone and its metabolite in body fluids and solid tissues in a fatal poisoning case measured by LC–MS–MS with the standard addition method

  2014cites this paper
• Validation of the only commercially available immunoassay for synthetic cathinones in urine: Randox Drugs of Abuse V Biochip Array Technology.

  2014cites this paper
• LC–MS/MS in the routine clinical laboratory: has its time come?

  2014cites this paper
• Development and Validation of Two Innovative Quantitative Liquid Chromatography Tandem Mass Spectrometry Methods for Forensic Toxicology Laboratories: Novel Analysis of Designer Drugs and Simultaneous Method for Cocaine and Opioids in Biological Matrices

  2014cites this paper
• Emerging drugs of abuse.

  2014cites this paper
• Postmortem distribution of α-pyrrolidinobutiophenone in body fluids and solid tissues of a human cadaver.

  2014cites this paper
• Forensic electrochemistry applied to the sensing of new psychoactive substances: electroanalytical sensing of synthetic cathinones and analytical validation in the quantification of seized street samples.

  2014cites this paper
• Role of LC-MS/MS in hair testing for the determination of common drugs of abuse and other psychoactive drugs.

  2013cites this paper
• Analysis of psychoactive cathinones and tryptamines by electrospray ionization atmospheric pressure ion mobility time-of-flight mass spectrometry.

  2013cites this paper
• MALDI-TOF mass spectrometric determination of four pyrrolidino cathinones in human blood

  2013cites this paper
• A fatal case of 3,4-methylenedioxypyrovalerone poisoning: coexistence of α-pyrrolidinobutiophenone and α-pyrrolidinovalerophenone in blood and/or hair

  2013cites this paper
• Rapid qualitative and quantitative analysis of novel drug analogues via Desorption Electrospray Ionisation - Mass Spectrometry (DESI-MS)

  2013cites this paper
• Comprehensive forensic toxicological analysis of designer drugs

  2013cites this paper
• Application of Novel Microporous Polyolefin Silica-Based Substrate in Paper Spray Mass Spectrometry (PS-MS)

  year unknowncites this paper